Skip to content

The Arthritis, Diet, and Activity Promotion Trial

The Arthritis, Diet, and Activity Promotion Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00979043
Acronym
ADAPT
Enrollment
318
Registered
2009-09-17
Start date
1997-11-30
Completion date
2000-12-31
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Keywords

knee osteoarthritis, weight-loss, exercise, obesity, physical function, total mortality

Brief summary

The primary purpose of this study was to determine the effect of dietary weight-loss, exercise training, or a combination of both on physical function in overweight and obese adults with knee osteoarthritis (OA). In secondary analyses, the effect of weight-loss and/or exercise on OA progression, self-reported pain and inflammation were examined. In post-trial analyses, the effect of dietary weight-loss on total mortality was determined.

Interventions

BEHAVIORALDietary Weight-loss

The goal of the dietary weight-loss intervention was to produce and maintain a mean weight-loss of 5% initial body weight during the 18-month intervention, using dietary counseling and behavior modification.

BEHAVIORALExercise

Participants participated in resistance training (15 minutes) and aerobic exercise (30 minutes) 3d/week for 18-months. The first 4-months of the exercise training were facility-based. After 4-months, participants were allowed to transition to a home-based intervention if they chose to.

Sponsors

National Institute on Aging (NIA)
CollaboratorNIH
Wake Forest University Health Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥ 60 years. * BMI ≥ 28 kg/m2. * Knee pain on most days of the month. * Sedentary lifestyle pattern (\<20 min exercise per week for last 6 months) * Self-reported difficulty with at least one of the following: walking 1/4 mile, climbing stairs, kneeling, bending, stooping, shopping, lifting, self-care. * Radiographic evidence of grade 1-3 knee osteoarthritis.

Exclusion criteria

* Serious medical condition that precludes safe participation in exercise such as heart disease (angina, congestive heart failure), severe hypertension, COPD, renal or liver disease, insulin-dependent diabetes. * Mini-mental state exam score \<24. * Inability to walks without a cane. * Reported alcohol consumption \>14 drinks/week. * Inability to complete protocol. * ST segment depression. * Participation in another research study.

Design outcomes

Primary

MeasureTime frame
self-reported physical function (WOMAC scale)baseline, 6-months, 18-months

Secondary

MeasureTime frame
timed stair climbingbaseline, 6-months, 18-months
weight-lossbaseline, 6-months, 18-months
self-reported painbaseline, 6-months, 18-months
6-minute walking distancebaseline, 6-months, 18-months
chronic inflammation, measured according to CRP, IL-6, IL-6 soluble receptor, TNF-alpha, TNF alpha receptors 1 and 2baseline and 18-months
total mortality7-9 yrs post-trial
progression of knee osteoarthritis, measured radiographicallybaseline, 6-months, 18-months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026